Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium vs Lamotrigine in Bipolar Disorder Type II
NCT06184581Phase 4Recruiting
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- May 2024
- Primary completion
- Dec 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium carbonate in Bipolar II disorder (BP-II), sponsored by Bispebjerg and Frederiksberg Hospital. Started May 2024; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT06184581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06184581.